Marcel Renn
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Cells and Metastasis
Papers in
-
- Immunotherapy and Immune Responses 5
- interferon and immune responses 4
- T-cell and B-cell Immunology 3
- Immune Response and Inflammation 2
- Oncology 4
- CAR-T cell therapy research 3
- Co-authors
- Thomas Tüting (6 shared papers)Tobias Bald (4 shared papers)Michael Hölzel (3 shared papers)Judith Kohlmeyer (4 shared papers)Jennifer Landsberg (2 shared papers)Mira Cron (3 shared papers)Thomas Wölfel (1 shared paper)Martina Fatho (1 shared paper)
In The Last Decade
Marcel Renn
13 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 87
- Immunology 583
- Oncology 534
- Cancer Research 87
- Molecular Biology 396
- Cell Biology 90
Countries citing papers authored by Marcel Renn
This map shows the geographic impact of Marcel Renn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcel Renn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcel Renn more than expected).
Fields of papers citing papers by Marcel Renn
This network shows the impact of papers produced by Marcel Renn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcel Renn. The network helps show where Marcel Renn may publish in the future.
Co-authors
The 25 scholars most cited alongside Marcel Renn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 469 | |
| 2 | 2014 | 209 | |
| 3 | 2015 | 151 | |
| 4 | 2021 | 80 | |
| 5 | 2016 | 71 | |
| 6 | 2013 | 48 | |
| 7 | 2009 | 38 | |
| 8 | 2010 | 30 | |
| 9 | Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide. | 2001 | 26 |
| 10 | 2022 | 23 | |
| 11 | 2021 | 16 | |
| 12 | 2023 | 13 | |
| 13 | 2024 | 4 |
About Marcel Renn
Marcel Renn is a scholar working on Immunology, Oncology, Infectious Diseases, Neurology and Cell Biology, having authored 13 papers that have together received 1.2k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (5 papers), interferon and immune responses (4 papers), COVID-19 Clinical Research Studies (3 papers), CAR-T cell therapy research (3 papers), T-cell and B-cell Immunology (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Inflammasome and immune disorders (2 papers) and Immune Response and Inflammation (2 papers). The work is most often cited by research in Immunology (583 citations), Oncology (534 citations), Cancer Research (87 citations), Molecular Biology (396 citations) and Cell Biology (90 citations). Marcel Renn has collaborated with scholars based in Germany, Belgium and Sweden. Frequent co-authors include Thomas Tüting, Tobias Bald, Michael Hölzel, Judith Kohlmeyer, Jennifer Landsberg, Mira Cron, Thomas Wölfel, Martina Fatho, Meri Rogava and Volker Lennerz. Their work appears in journals such as Molecular Therapy — Nucleic Acids, Pharmacology & Therapeutics, Journal of Molecular Cell Biology, Nature and Pigment Cell & Melanoma Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.